Brickell Biotech has appointed Robert Brown to serve as CEO, starting Jan. 1. He will also join the Boulder, CO, company’s board of directors. Brown is taking the place of CEO and co-founder Reginald Hardy, who will remain on the board and will serve as an advisor to his successor. Brown is currently chief marketing officer and senior vice president at Eli Lilly (NYSE: LLY). Brickell is preparing to start two Phase 3 studies testing its lead drug candidate, sofpironium bromide, as a treatment for axillary hyperhidrosis—excessive underarm sweating.